Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT3 | O60678 | 1/20 | 0.89 |
| ▸ | EP300 | Q09472 | 1/20 | 0.89 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.89 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.89 |
| ▸ | ENPP2 | Q13822 | 12/20 | 0.71 |
| ▸ | CD40 | P25942 | 1/20 | 0.67 |
| ▸ | CD40LG | P29965 | 1/20 | 0.67 |
| ▸ | CA2 | P00918 | 1/20 | 0.51 |
| ▸ | CA3 | P07451 | 1/20 | 0.51 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | PHLPP2 | Q6ZVD8 | 1/20 | 0.46 |
| ▸ | MPL | P40238 | 1/20 | 0.44 |
| ▸ | CTRC | Q99895 | 1/20 | 0.44 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29637780 | 0.94 | PRMT1 (1.00) | PRMT3EP300PRMT6PRMT1ENPP2 | |
| SCHEMBL23259402 | 0.94 | PRMT1 (1.00) | PRMT3EP300PRMT6PRMT1ENPP2 | |
| SCHEMBL30371624 | 0.94 | PRMT1 (0.98) | PRMT3EP300PRMT6PRMT1ENPP2 | |
| SCHEMBL10623011 | 0.94 | PRMT1 (0.98) | PRMT3EP300PRMT6PRMT1ENPP2 | |
| SCHEMBL10623083 | 0.94 | PRMT1 (0.98) | PRMT3EP300PRMT6PRMT1ENPP2 | |
| SCHEMBL29538633 | 0.88 | ENPP2 (0.86) | PRMT3EP300PRMT6PRMT1ENPP2 | |
| SCHEMBL10622996 | 0.86 | PRMT1 (0.84) | PRMT3EP300PRMT6PRMT1ENPP2 | |
| SCHEMBL13046146 | 0.84 | PRMT1 (0.79) | PRMT3EP300PRMT6PRMT1ENPP2 | |
| SCHEMBL20621514 | 0.84 | PRMT1 (0.80) | PRMT3EP300PRMT6PRMT1ENPP2 | |
| SCHEMBL29926756 | 0.83 | ENPP2 (0.79) | PRMT3EP300PRMT6PRMT1ENPP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9504637-B2 | Coloring agents and methods of use thereof | LIVING PROOF, INC. (US) | 2016-11-29 | — | — | US | disclosed |
| US-20160106648-A1 | COLORING AGENTS AND METHODS OF USE THEREOF | LIVING PROOF, INC. (US) | 2016-04-21 | — | — | US | disclosed |
| US-9248086-B2 | Coloring agents and methods of use thereof | LIVING PROOF, INC. (US) | 2016-02-02 | — | — | US | disclosed |
| US-20150174026-A1 | COLORING AGENTS AND METHODS OF USE THEREOF | LIVING PROOF, INC. | 2015-06-25 | — | — | US | disclosed |
| US-8932370-B2 | Coloring agents and methods of use thereof | LIVING PROOF, INC. (US) | 2015-01-13 | — | — | US | disclosed |
| US-20140326269-A1 | COLORING AGENTS AND METHODS OF USE THEREOF | LIVING PROOF, INC. | 2014-11-06 | — | — | US | disclosed |
| US-8758451-B2 | Coloring agents and methods of use thereof | LIVING PROOF, INC. (US) | 2014-06-24 | — | — | US | disclosed |
| US-20140013520-A1 | COLORING AGENTS AND METHODS OF USE THEREOF | LIVING PROOF, INC. | 2014-01-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160106648-A1 | COLORING AGENTS AND METHODS OF USE THEREOF | MPO, HLA-C, ADH7 | PRMT3 1928/4885EP300 621/4885PRMT6 2697/4885 |
| US-20140013520-A1 | COLORING AGENTS AND METHODS OF USE THEREOF | MPO, HLA-C, ADH7 | PRMT3 1928/4885EP300 621/4885PRMT6 2697/4885 |
| US-20150174026-A1 | COLORING AGENTS AND METHODS OF USE THEREOF | MPO, HLA-C, ADH7 | PRMT3 1928/4885EP300 621/4885PRMT6 2697/4885 |
| US-20140326269-A1 | COLORING AGENTS AND METHODS OF USE THEREOF | MPO, HLA-C, ADH7 | PRMT3 1928/4885EP300 621/4885PRMT6 2697/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.